NCT02755038

Brief Summary

The investigators hypothesis is that we can determine estrogen and progesterone levels in the hair by using the immune method and we can show a significant difference in the levels of these hormones in both groups of women: pre- and postmenopausal women. If indeed it would then be possible in future to carry out research that can find a relationship between the levels of these hormones and various diseases

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 28, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

April 28, 2016

Status Verified

April 1, 2016

Enrollment Period

10 months

First QC Date

April 19, 2016

Last Update Submit

April 26, 2016

Conditions

Keywords

postmenopausal womenscalp hairestrogenprogesterone

Outcome Measures

Primary Outcomes (2)

  • concentration of hair scalp progesterone

    concentration of hair scalp progesterone (nmol\\L)

    3 months

  • concentration of hair scalp estrogen

    concentration of hair scalp estrogen (pmol\\L)

    3 months

Study Arms (1)

premenopausal and postmenopausal women

One group will include 20 premenopausal women under the age 40 years old, with regular menstruation cycles and without any illness or medication including birth control pills or steroidal ointments, and without known diagnosis of polycystic ovaries or fertility disorder. The second group will include 20 postmenopausal women over the age of 60, with no menstruation at least for the last five years, and without hormone therapy or treatment of any Steroidal therapy for the last year.

Eligibility Criteria

Age20 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

One group will include 20 women under the age 40 years old, with regular menstruation cycles and without any illness or medication including birth control pills or steroidal ointments, and without known diagnosis of polycystic ovaries or fertility disorder. The second group will include 20 women over the age of 60, with no menstruation at least for the last five years, and without hormone therapy or treatment of any Steroidal therapy for the last year.

You may qualify if:

  • women under 40 with regular cycles
  • Women over the age of 60 in menopause for at least 5 years

You may not qualify if:

  • pregnant women
  • oral contraceptive treatment in the last year
  • hormonal replacement therapy in the last year
  • month after delivery
  • infertile women
  • irregular menstruation
  • women with progesterone secretion intrauterine device in the last year
  • BMI- Body Mass Index- below 25 or above 35
  • Polycystic Ovarian Syndrome
  • steriodal treatment including inhalers and ointments.
  • status post Removal of the ovaries or uterus
  • Breast or uterine cancer in the past.
  • any pituitary or adrenal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samer Khoury

Haifa, 31048, Israel

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Scalp Hair

Study Officials

  • samer khoury

    Bnai Zion Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

samer khoury, MD

CONTACT

Einav Kadour

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

April 19, 2016

First Posted

April 28, 2016

Study Start

March 1, 2016

Primary Completion

January 1, 2017

Study Completion

March 1, 2017

Last Updated

April 28, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations